S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
Log in
NASDAQ:MASI

Masimo Stock Forecast, Price & News

$251.06
-6.03 (-2.35 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$249.36
Now: $251.06
$258.70
50-Day Range
$257.09
MA: $267.86
$283.75
52-Week Range
$143.90
Now: $251.06
$284.86
Volume303,684 shs
Average Volume282,396 shs
Market Capitalization$13.82 billion
P/E Ratio65.21
Dividend YieldN/A
Beta0.87
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software for Masimo Root and Radical-7 monitors. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, home care providers, long term care facilities, veterinarians, and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.
Masimo logo

MarketRank

Overall MarketRank

1.37 out of 5 stars

Medical Sector

578th out of 1,925 stocks

Electromedical Equipment Industry

15th out of 61 stocks

Analyst Opinion: 1.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:MASI
CUSIP57479510
Phone949-297-7000
Employees1,600
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$937.84 million
Cash Flow$3.53 per share
Book Value$21.90 per share

Profitability

Net Income$196.22 million

Miscellaneous

Market Cap$13.82 billion
Next Earnings Date2/23/2021 (Confirmed)
OptionableOptionable
$251.06
-6.03 (-2.35 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Masimo (NASDAQ:MASI) Frequently Asked Questions

How has Masimo's stock been impacted by Coronavirus (COVID-19)?

Masimo's stock was trading at $182.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MASI stock has increased by 37.5% and is now trading at $251.06.
View which stocks have been most impacted by COVID-19
.

Is Masimo a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Masimo stock.
View analyst ratings for Masimo
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Masimo?

Wall Street analysts have given Masimo a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Masimo wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo CEO Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among Masimo's employees.

When is Masimo's next earnings date?

Masimo is scheduled to release its next quarterly earnings announcement on Tuesday, February 23rd 2021.
View our earnings forecast for Masimo
.

How can I listen to Masimo's earnings call?

Masimo will be holding an earnings conference call on Tuesday, February 9th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) issued its quarterly earnings data on Saturday, October, 31st. The medical equipment provider reported $0.80 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.62 by $0.18. The medical equipment provider earned $278.11 million during the quarter, compared to analysts' expectations of $275 million. Masimo had a trailing twelve-month return on equity of 15.75% and a net margin of 20.30%.
View Masimo's earnings history
.

What guidance has Masimo issued on next quarter's earnings?

Masimo updated its FY21 earnings guidance on Wednesday, January, 13th. The company provided earnings per share guidance of $3.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.82.

What price target have analysts set for MASI?

7 brokers have issued 1-year target prices for Masimo's stock. Their forecasts range from $201.00 to $310.00. On average, they expect Masimo's share price to reach $261.17 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price.
View analysts' price targets for Masimo
or view Wall Street analyst' top-rated stocks.

Are investors shorting Masimo?

Masimo saw a decline in short interest in December. As of December 31st, there was short interest totaling 1,100,000 shares, a decline of 14.1% from the December 15th total of 1,280,000 shares. Based on an average trading volume of 343,300 shares, the short-interest ratio is currently 3.2 days. Approximately 2.2% of the company's stock are sold short.
View Masimo's Short Interest
.

Who are some of Masimo's key competitors?

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), The Trade Desk (TTD), The Walt Disney (DIS) and Twilio (TWLO).

Who are Masimo's key executives?

Masimo's management team includes the following people:
  • Mr. Joseph E. Kiani, Founder, CEO & Chairman (Age 56, Pay $3M)
  • Mr. Micah Young, Exec. VP of Fin. & CFO (Age 42, Pay $713.37k)
  • Mr. Bilal Muhsin, Chief Operating Officer (Age 40, Pay $892.51k)
  • Dr. Steven J. Barker, Chairman of Scientific Advisory Board, Chief Science Officer & Director (Age 76, Pay $190k)
  • Mr. Thomas Samuel McClenahan, Exec. VP, Gen. Counsel & Corp. Sec. (Age 48, Pay $718.05k)
  • Mr. Anand Sampath, Exec. VP of Operations & Clinical Research (Age 55, Pay $774.84k)
  • Mr. J. Todd Koning, Sr. VP & Chief Accounting Officer (Age 49)
  • Mr. Yongsam Lee, Exec. VP & Chief Information Officer (Age 56)
  • Mr. Eli Kammerman, VP of Bus. Devel. & Investor Relations
  • Mr. Jon Coleman, Pres of Worldwide Sales, Professional Services & Medical Affairs (Age 57)

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a variety of institutional and retail investors. Top institutional investors include New York State Teachers Retirement System (0.12%), Scout Investments Inc. (0.12%), State of Alaska Department of Revenue (0.07%), Strs Ohio (0.07%), Boston Trust Walden Corp (0.07%) and Forte Capital LLC ADV (0.07%). Company insiders that own Masimo stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends for Masimo
.

Which major investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio, Boston Trust Walden Corp, Pacer Advisors Inc., Scout Investments Inc., New York State Teachers Retirement System, Paradigm Capital Management Inc. NY, State of Alaska Department of Revenue, and Tributary Capital Management LLC. Company insiders that have sold Masimo company stock in the last year include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Thomas Samuel Mcclenahan, and Yongsam Lee.
View insider buying and selling activity for Masimo
or view top insider-selling stocks.

Which major investors are buying Masimo stock?

MASI stock was acquired by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., Mitsubishi UFJ Asset Management UK Ltd., Forte Capital LLC ADV, Exchange Traded Concepts LLC, IFM Investors Pty Ltd, Congress Asset Management Co. MA, V Wealth Advisors LLC, and Procyon Private Wealth Partners LLC.
View insider buying and selling activity for Masimo
or or view top insider-buying stocks.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $251.06.

How big of a company is Masimo?

Masimo has a market capitalization of $13.82 billion and generates $937.84 million in revenue each year. The medical equipment provider earns $196.22 million in net income (profit) each year or $3.22 on an earnings per share basis. Masimo employs 1,600 workers across the globe.

What is Masimo's official website?

The official website for Masimo is www.masimo.com.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.